Ad
related to: treatment for asthma nhs foundation plan 2 pdf format sample
Search results
Results from the WOW.Com Content Network
The Buteyko method emphasizes the role of carbon dioxide and hyperventilation in respiratory diseases as well as overall health. It is known that hyperventilation can lead to low carbon dioxide levels in the blood (or hypocapnea), which can subsequently lead to disturbances of the acid-base balance in the blood and lower tissue oxygen levels.
Brittle asthma is a type of asthma distinguishable from other forms by recurrent, severe attacks. [1] [2] [3] There are two subtypes divided by symptoms: Type 1 and Type 2, [4] depending on the stability of the patient's maximum speed of expiration, or peak expiratory flow rate (PEFR).
Medication therapy management, generally called medicine use review in the United Kingdom, is a service provided typically by pharmacists, medical affairs, and RWE scientists that aims to improve outcomes by helping people to better understand their health conditions and the medications used to manage them. [1]
Bronchial thermoplasty [1] is a treatment for severe asthma approved by the FDA in 2010 involving the delivery of controlled, therapeutic radiofrequency energy to the airway wall, thus heating the tissue and reducing the amount of smooth muscle present in the airway wall.
Overuse of β 2 agonists and asthma treatment without proper inhaled corticosteroid use has been associated with an increased risk of asthma exacerbations and asthma-related hospitalizations. [8] The excipients, in particular sulfite, could contribute to the adverse effects.
Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).
Asthma + Lung UK (formally Asthma and Lung UK) is a British charity based in London, England. It focuses on respiratory health, in particular asthma and lung disease. [2] [3] The organisation was formed in January 2020 as Asthma UK and the British Lung Foundation Partnership as a result of a merger between Asthma UK and the British Lung Foundation.
Cardiac asthma is the medical condition of intermittent wheezing, coughing, and shortness of breath that is associated with underlying congestive heart failure (CHF). [1] Symptoms of cardiac asthma are related to the heart's inability to effectively and efficiently pump blood in a CHF patient. [2]
Ad
related to: treatment for asthma nhs foundation plan 2 pdf format sample